(Q34745153)

4 August 2017

1 reference

title

Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma (English)

1 reference

4 August 2017

1 reference

1 reference

2

R N Brogden

1 reference

4 August 2017

J C Adkins

1

1 reference

PubMed ID

9463793

4 August 2017

language of work or name

1 reference

1 January 1998

1 reference

4 August 2017

1 reference

4 August 2017

55

1 reference

4 August 2017

1

1 reference

4 August 2017

121-144

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199855010-00008

4 August 2017

0 references

cites work

Preclinical exploration of the potential antiinflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate).

1 reference

12 December 2020

An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways

1 reference

12 December 2020

Cysteinyl-leukotriene receptor antagonist, bronchoconstriction, and airway hyperreactivity

1 reference

12 December 2020

Exercise-induced asthma: a practical guide to definitions, diagnosis, prevalence, and treatment.

1 reference

12 December 2020

Mucosal inflammation in asthma

1 reference

12 December 2020

Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma

1 reference

12 December 2020

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

1 reference

12 December 2020

Effects of leukotriene D on the airways in asthma

1 reference

12 December 2020

The emergence of potent and selective peptide leukotriene receptor antagonists

1 reference

12 December 2020

Urinary Excretion of Leukotriene E4and 11-dehydro-Thromboxane B2in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in Asthmatics

1 reference

12 December 2020

Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219

1 reference

12 December 2020

Inhaled ICI 204,219 blocks antigen-induced bronchoconstriction in subjects with bronchial asthma

1 reference

12 December 2020

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

1 reference

12 December 2020

Clinical and experimental studies of leukotrienes as mediators of airway obstruction in humans

1 reference

12 December 2020

Administration errors with a conventional metered dose inhaler versus a novel breath actuated device

1 reference

12 December 2020

Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro

1 reference

12 December 2020

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

1 reference

12 December 2020

The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics

1 reference

12 December 2020

Recovery of Leukotriene E4from the Urine of Patients with Airway Obstruction

1 reference

12 December 2020

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist

1 reference

12 December 2020

Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions

1 reference

12 December 2020

Practical issues in asthma management: correct use of inhalation devices

1 reference

12 December 2020

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects

1 reference

12 December 2020

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

12 December 2020

Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects.

1 reference

12 December 2020

Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy.

1 reference

12 December 2020

Leukotrienes in the pathogenesis of asthma

1 reference

12 December 2020

Bronchoconstrictor effects of leukotriene C in humans

1 reference

12 December 2020

Anti-leukotriene agents: a new direction in asthma therapy

1 reference

12 December 2020

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

1 reference

12 December 2020

Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction

1 reference

12 December 2020

Leukotriene activity modulation in asthma

1 reference

12 December 2020

Leukotrienes as a target in asthma therapy

1 reference

12 December 2020

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

1 reference

12 December 2020

The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction

1 reference

12 December 2020

Anti-leukotriene intervention: is there adequate information for clinical use in asthma?

1 reference

12 December 2020

Leukotriene E4 and granulocytic infiltration into asthmatic airways

1 reference

12 December 2020

Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma

1 reference

12 December 2020

Leukotrienes C4, D4, and E4 enhance histamine responsiveness in asthmatic airways.

1 reference

12 December 2020

Arachidonic acid metabolites: mediators of inflammation in asthma.

1 reference

12 December 2020

Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.

1 reference

12 December 2020

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

1 reference

12 December 2020

Leukotrienes in asthma. The potential therapeutic role of antileukotriene agents

1 reference

12 December 2020

Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge

1 reference

12 December 2020

Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.

1 reference

12 December 2020

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma

1 reference

12 December 2020

Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis

1 reference

12 December 2020

The role of leukotrienes in asthma and allergic rhinitis

1 reference

12 December 2020

Leukotrienes are potent constrictors of human bronchi

1 reference

12 December 2020

10.2165/00003495-199855010-00008

Identifiers

DOI

1 reference

PubMed ID

9463793

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

9463793